Diet-induced Elevations in LDL-C and Progression of Atherosclerosis - Trial NCT05733325
Access comprehensive clinical trial information for NCT05733325 through Pure Global AI's free database. This phase not specified trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center and is currently Not yet recruiting. The study focuses on Hypercholesterolemia. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Timeline & Enrollment
N/A
Oct 18, 2021
May 01, 2024
Primary Outcome
Percent change in total non-calcified coronary plaque volume
Summary
This is an observational study examining the progression of subclinical coronary
 atherosclerosis in healthy participants who have an elevated LDL-C (above 190mg/dl) secondary
 to diet not associated with genetic familial hypercholesterolemia (FH). This study
 participants are classified to be Lean-Mass-Hyper-Responder (LMHR).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05733325
Non-Device Trial